Autoimmune Treatment Global Market Report 2024

Description

Autoimmune Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autoimmune treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autoimmune treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autoimmune treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Consumables and Assay Kits; Instruments; Services
2) By Service Type: Consultation and Diagnosis; Therapy and monitoring; Drug development
3) By Disease: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Sjogren's Syndrome; Thyroiditis; Scleroderma; Other Diseases
4) By Drug Class: Anti-Inflammatory; Anti-Hyperglycemic; NSAIDs; Interferons; Other Drug Class
5) By End User: Clinical Laboratories; Hospitals; Other End Users
Companies Mentioned: Abbott Laboratories; Amgen Inc.; Johnson & Johnson Services Inc.; Eli Lilly and Company; Pfizer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Autoimmune treatment encompasses the strategic management and support provided to patients to address autoimmune diseases or disorders. In these conditions, the immune system targets the body's own cells. The application of autoimmune treatment aims to effectively address and manage autoimmune diseases.

In the realm of autoimmune treatment, the primary product categories comprise consumables and assay kits, instruments, and services. Consultation denotes the act of seeking guidance from physicians or healthcare professionals for diagnostic studies, therapeutic interventions, or related services. Diagnosis, on the other hand, involves the systematic identification of the nature of an illness or problem through the examination of signs and symptoms. The principal service types encompass consultation and diagnosis, therapy and monitoring, and drug development, with a focus on various diseases such as rheumatoid arthritis, systemic lupus erythematosus, sjogren's syndrome, thyroiditis, scleroderma, among others. Key drug classes integral to autoimmune treatment include anti-inflammatory agents, anti-hyperglycemics, NSAIDs, interferons, and others. Clinical laboratories, hospitals, and similar entities constitute the primary end users in this domain.

The autoimmune treatment market report is one of a series of new reports from The Business Research Company that provides autoimmune treatment statistics, including autoimmune treatment industry global market size, regional shares, competitors with an autoimmune treatment market share, detailed autoimmune treatment market segments, market trends and opportunities, and any further data you may need to thrive in the autoimmune treatment industry. This autoimmune treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autoimmune treatment market size has grown rapidly in recent years. It will grow from $6.83 billion in 2023 to $7.68 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth observed in the historical period can be ascribed to several factors, including the rising prevalence of the condition, advancements in the field of immunology, insights gained from genetic research, heightened awareness and advocacy among patients, as well as supportive regulatory measures.

The autoimmune treatment market size is expected to see rapid growth in the next few years. It will grow to $12.64 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The anticipated growth in the forecast period can be attributed to the adoption of precision medicine approaches, the emergence of small molecule therapies, the exploration of novel pathways in treatment, innovations in gene therapy, increased investments in biopharmaceuticals, and the expanding biosimilar market. Key trends expected in the forecast period encompass advancements in biologics and targeted therapies, the development of immunomodulatory treatments, a heightened focus on rare autoimmune diseases, the integration of telemedicine and remote monitoring, regulatory initiatives facilitating drug approvals, and the incorporation of digital health tools.

The autoimmune treatment market is set to experience significant growth due to increased investments in research and development (R&D) for drugs targeting autoimmune diseases. R&D initiatives facilitate the innovation and introduction of new products and services. Specifically, R&D efforts in autoimmune disease drugs enable the creation of more precise, low-molecular-weight, orally active, and well-characterized immune suppressive drugs with tolerable long-term treatment profiles. Notably, in January 2022, Eli Lilly and Company, a US-based pharmaceutical giant, raised its R&D investment from $7 billion in 2021 to $7.19 billion in 2022, elevating its R&D expenditure as a percentage of revenue from 24.8% to 25.19%. This surge in R&D investments propels growth within the autoimmune treatment market.

The escalation in healthcare expenditures is poised to drive the growth trajectory of the autoimmune treatment market. Healthcare expenditures encompass all costs associated with delivering health services, including initiatives like family planning, nutrition programs, and emergency health aid, with a focus on overall health improvement. An upsurge in healthcare spending typically leads to the development of more efficient therapies and advancements in medical technologies for treating autoimmune conditions. For instance, according to the American Medical Association in March 2023, healthcare spending in the United States surged by 2.7% to $12,914 per person in 2021, totaling $4.3 trillion. This upward trend in healthcare expenditures is a significant driver fueling growth in the autoimmune treatment market.

Technological advancements emerge as a pivotal trend shaping the landscape of the autoimmune treatment market. Major market players are actively investing in advanced technologies to solidify their positions. Notably, in June 2023, Belgium-based pharmaceutical company UCB received approval from the U.S. Food and Drug Administration (FDA) for RYSTIGGO (rozanolixizumab-noli) to treat generalized myasthenia gravis (gMG) in adults who test positive for anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies. This approval, expedited under Priority Review, marks RYSTIGGO as the exclusive FDA-approved therapy for both anti-AchR and anti-MuSK antibody-positive gMG, encompassing the two most prevalent subtypes of this autoimmune condition. This breakthrough signifies a potential enhancement in provider efficiency, treatment efficacy, and overall patient care within the autoimmune illness domain.

Prominent players in the autoimmune treatment market are intensifying their focus on introducing cutting-edge clinical trial platforms as a strategic move to gain a competitive advantage. These innovative platforms in autoimmune treatment capitalize on advanced technologies and personalized methodologies to enhance treatment efficacy, safety, and overall patient outcomes. For instance, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, introduced the CONQUEST trial platform. This groundbreaking initiative aims to advance research and therapeutic approaches for scleroderma, a rare autoimmune disease impacting connective tissues. The CONQUEST program addresses pivotal challenges in clinical development, fostering advancements in scleroderma treatment methodologies. Notably, the CONQUEST platform clinical trial represents a pioneering effort in rare autoimmune diseases, specifically focusing on swiftly evaluating potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) and overall SSc outcomes, encompassing aspects such as skin and other disease manifestations.

In another significant development in August 2023, Eli Lilly and Company, a US-based pharmaceutical giant, completed the acquisition of DICE Therapeutics, Inc. for $2.4 billion. This strategic acquisition expands Lilly's portfolio in the realm of immunology products by integrating DICE's innovative oral therapeutic candidates. Notably, DICE Therapeutics, Inc., a US-based pharmaceutical firm, specializes in developing novel oral therapies targeting autoimmune and inflammatory conditions. Specifically, DICE's oral IL-17 inhibitors, presently undergoing clinical development, are poised to offer innovative treatment approaches for chronic immunological disorders, broadening Lilly's offerings in this therapeutic domain.

Major companies operating in the autoimmune treatment market report are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., Celsion Corporation, ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CRISPR Therapeutics AG, CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.

North America was the largest region in the autoimmune treatment market in 2023. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the autoimmune treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The autoimmune treatment includes revenues earned by entities by providing immunosuppressive therapy, biological treatment, immuno-suppressing medications services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12478

1. Executive Summary

2. Autoimmune Treatment Market Characteristics

3. Autoimmune Treatment Market Trends And Strategies

4. Autoimmune Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Autoimmune Treatment Market Size and Growth

5.1. Global Autoimmune Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Autoimmune Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Autoimmune Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Autoimmune Treatment Market Segmentation

6.1. Global Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Consumables and Assay Kits
Instruments
Services
6.2. Global Autoimmune Treatment Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Consultation and Diagnosis
Therapy and monitoring
Drug development
6.3. Global Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Sjogren's Syndrome
Thyroiditis
Scleroderma
Other Diseases
6.4. Global Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinical Laboratories
Hospitals
Other End Users

7. Autoimmune Treatment Market Regional And Country Analysis

7.1. Global Autoimmune Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Autoimmune Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Autoimmune Treatment Market

8.1. Asia-Pacific Autoimmune Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Autoimmune Treatment Market

9.1. China Autoimmune Treatment Market Overview
9.2. China Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Autoimmune Treatment Market

10.1. India Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Autoimmune Treatment Market

11.1. Japan Autoimmune Treatment Market Overview
11.2. Japan Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Autoimmune Treatment Market

12.1. Australia Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Autoimmune Treatment Market

13.1. Indonesia Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Autoimmune Treatment Market

14.1. South Korea Autoimmune Treatment Market Overview
14.2. South Korea Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Autoimmune Treatment Market

15.1. Western Europe Autoimmune Treatment Market Overview
15.2. Western Europe Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Autoimmune Treatment Market

16.1. UK Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Autoimmune Treatment Market

17.1. Germany Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Autoimmune Treatment Market

18.1. France Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Autoimmune Treatment Market

19.1. Italy Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Autoimmune Treatment Market

20.1. Spain Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Autoimmune Treatment Market

21.1. Eastern Europe Autoimmune Treatment Market Overview
21.2. Eastern Europe Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Autoimmune Treatment Market

22.1. Russia Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Autoimmune Treatment Market

23.1. North America Autoimmune Treatment Market Overview
23.2. North America Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Autoimmune Treatment Market

24.1. USA Autoimmune Treatment Market Overview
24.2. USA Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Autoimmune Treatment Market

25.1. Canada Autoimmune Treatment Market Overview
25.2. Canada Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Autoimmune Treatment Market

26.1. South America Autoimmune Treatment Market Overview
26.2. South America Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Autoimmune Treatment Market

27.1. Brazil Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Autoimmune Treatment Market

28.1. Middle East Autoimmune Treatment Market Overview
28.2. Middle East Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Autoimmune Treatment Market

29.1. Africa Autoimmune Treatment Market Overview
29.2. Africa Autoimmune Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Autoimmune Treatment Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Autoimmune Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Autoimmune Treatment Market Competitive Landscape And Company Profiles

30.1. Autoimmune Treatment Market Competitive Landscape
30.2. Autoimmune Treatment Market Company Profiles
- 30.2.1. Abbott Laboratories
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Amgen Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Johnson & Johnson Services Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Eli Lilly and Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Pfizer Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Autoimmune Treatment Market Competitive Benchmarking

32. Global Autoimmune Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Autoimmune Treatment Market

34. Autoimmune Treatment Market Future Outlook and Potential Analysis

34.1 Autoimmune Treatment Market In 2028 - Countries Offering Most New Opportunities
34.2 Autoimmune Treatment Market In 2028 - Segments Offering Most New Opportunities
34.3 Autoimmune Treatment Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer